INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Integra Lifesciences Holdings Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Integra Lifesciences Holdings Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$9.67M, a 989% decline year-over-year.
  • Integra Lifesciences Holdings Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$5.38M, a 135% decline year-over-year.
  • Integra Lifesciences Holdings Corp annual Income Tax Expense (Benefit) for 2023 was $13.3M, a 60% decline from 2022.
  • Integra Lifesciences Holdings Corp annual Income Tax Expense (Benefit) for 2022 was $33.3M, a 26.9% decline from 2021.
  • Integra Lifesciences Holdings Corp annual Income Tax Expense (Benefit) for 2021 was $45.6M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.38M -$9.67M -$8.78M -989% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $3.4M -$2.78M -$2.42M -673% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $5.83M -$1.95M -$7.5M -135% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $13.3M $9.02M -$2.24M -19.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $15.6M -$888K -$9.77M -110% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $25.3M -$360K -$7.15M -105% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $32.5M $5.55M -$862K -13.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $33.3M $11.3M +$4.86M +75.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $28.5M $8.88M +$1.32M +17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 $27.2M $6.79M -$2.97M -30.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $30.1M $6.41M -$15.5M -70.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 $45.6M $6.4M +$60.2M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$14.6M $7.56M -$1.62M -17.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$13M $9.76M +$7.74M +383% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$20.8M $21.9M +$19.6M +867% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 -$40.4M -$53.8M -$64.9M -585% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $24.5M $9.17M +$9.07M +8983% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $15.5M $2.02M -$4.63M -69.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $20.1M $2.26M +$10.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $9.9M $11.1M +$11.7M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$1.81M $101K +$2.37M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$4.18M $6.65M +$5.29M +391% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$9.47M -$7.93M -$6.07M -327% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$3.4M -$622K +$48.3M +98.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 -$51.7M -$2.27M -$2.35M -3088% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 -$49.4M $1.36M +$4.19M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 -$53.6M -$1.86M -$211K -12.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$53.4M -$49M -$56.2M -777% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $2.82M $76K -$4.77M -98.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $7.6M -$2.83M -$5.02M -229% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $12.6M -$1.65M -$3.23M -205% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $15.8M $7.23M +$2.7M +59.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $13.1M $4.85M -$32.4M -87% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $45.5M $2.19M -$3.8M -63.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $49.3M $1.58M -$4.48M -74% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $53.8M $4.53M +$1.36M +42.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $52.5M $37.2M +$35.3M +1793% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $17.2M $5.99M +$3.63M +154% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $13.6M $6.06M +$4.29M +242% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $9.27M $3.17M -$2.76M -46.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $12M $1.97M +$8.32M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $3.71M $2.36M +$3.31M Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $401K $1.77M +$3.64M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 -$3.24M $5.93M +$2.11M +55.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$5.35M -$6.35M -$7.4M -708% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $2.05M -$947K -$4M -131% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $6.05M -$1.87M -$4.77M -165% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $10.8M $3.83M +$8.01M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $2.82M $1.05M +$1M +2275% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $1.82M $3.06M +$1.76M +135% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-02
Q1 2012 $59K $2.9M -$446K -13.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $505K -$4.18M -$4.82M -761% Oct 1, 2011 Dec 31, 2011 8-K 2014-06-20
Q3 2011 $5.32M $44K -$5.74M -99.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 $11.1M $1.3M -$4.64M -78.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-31
Q1 2011 $15.7M $3.35M -$741K -18.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $16.4M $633K Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $5.79M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $5.94M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $4.09M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.